Effect of dexmedetomidine combined with azasetron postoperative intravenous analgesia on postoperative nausea and vomiting in women undergoing posterior lumbar fusion surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049246

Enrollment

Unknown

Registered

2021-07-28

Start date

2021-07-26

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group DA:Dexmedetomidine + Azasetron

Group D:Dexmedetomidine

Group A:Azasetron

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA classification 1-2; 2. Aged 18-65 years, female, BMI 18-30; 3. Posterior lumbar spine surgery is planned for >2 segments, and postoperative analgesia is required.

Exclusion criteria

Exclusion criteria: 1. Allergic to the drugs required for the study; 2. Sinus bradycardia, II° and above atrioventricular block; 3. Unable to cooperate with the completion of postoperative follow-up.

Design outcomes

Primary

Measure	Time frame
Postoperative nausea and vomiting;Remedial antiemetic;	—

Secondary

Measure	Time frame
Side effects;ramsay sedation score;NRS pain score;Remedial anagetics;	—

Countries

China

Contacts

Public ContactLi Juan

Southern District of Anhui Provincial Hospital

huamuzi1999@126.com+86 18963789077

Outcome results